Benjamin Halladay
Director of Finance/CFO at ESPERION THERAPEUTICS, INC.
Net worth: 653 748 $ as of 31/03/2024
Profile
Benjamin Halladay is currently the Chief Financial Officer at Esperion Therapeutics, Inc. He previously worked as the Global Finance Manager at NOV, Inc. from 2016 to 2017.
Mr. Halladay completed his undergraduate degree at Syracuse University and holds an MBA from Fordham Gabelli School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/03/2024 | 243,936 ( 0.14% ) | 653 748 $ | 31/03/2024 |
Benjamin Halladay active positions
| Companies | Position | Start |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Director of Finance/CFO | 16/11/2022 |
Former positions of Benjamin Halladay
| Companies | Position | End |
|---|---|---|
| NOV INC. | Corporate Officer/Principal | 01/05/2017 |
Training of Benjamin Halladay
| Syracuse University | Undergraduate Degree |
| Fordham Gabelli School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| NOV INC. | Industrial Services |
- Stock Market
- Insiders
- Benjamin Halladay